Summary for ARTG Entry:
AXIRON testosterone 2% w/v solution bottle
ARTG entry for
Eli Lilly Australia Pty Ltd
112 Wharf Road,WEST RYDE, NSW, 2114
ARTG Start Date
Drug Safety Evaluation Branch
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Single Medicine Product
See Product Information and Consumer Medicine Information for this product
Androgen replacement therapy for confirmed testosterone deficiency in males.
Additional Product information
Store below 25
Store in Original
Pack Size/Poison information
(S4) Prescription Only Medicine
Route of Administration
2 % w/v
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 29.11.2017 at 07:04:03 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information